CIBC Private Wealth Group’s CorMedix CRMD Stock Holding History

CIBC Private Wealth Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$488K	Hold	42,000	–	–	﹤0.01%	888
2025 Q3	$488K	Hold	42,000	–	–	﹤0.01%	871
2025 Q2	$517K	Hold	42,000	–	–	﹤0.01%	828
2025 Q1	$285K	Hold	42,000	–	–	﹤0.01%	969
2024 Q4	$454K	Hold	42,000	–	–	﹤0.01%	896
2024 Q3	$339K	Hold	42,000	–	–	﹤0.01%	988
2024 Q2	$176K	Hold	42,000	–	–	﹤0.01%	1157
2024 Q1	$175K	Hold	42,000	–	–	﹤0.01%	1179
2023 Q4	$158K	Hold	42,000	–	–	﹤0.01%	1086
2023 Q3	$155K	Hold	42,000	–	–	﹤0.01%	1015
2023 Q2	$167K	Hold	42,000	–	–	﹤0.01%	847
2023 Q1	$174K	Hold	42,000	–	–	﹤0.01%	851
2022 Q4	$177	Hold	42,000	–	–	﹤0.01%	820
2022 Q3	$119K	Hold	42,000	–	–	﹤0.01%	872
2022 Q2	$169K	Buy	42,000 +22,869	+120%	+$85K	﹤0.01%	897
2022 Q1	$105K	Buy	19,131 +7,131	+59%	+$32.7K	﹤0.01%	998
2021 Q4	$55K	Hold	12,000	–	–	﹤0.01%	997
2021 Q3	$56K	Hold	12,000	–	–	﹤0.01%	920
2021 Q2	$82K	Hold	12,000	–	–	﹤0.01%	1015
2021 Q1	$120K	Hold	12,000	–	–	﹤0.01%	1011
2020 Q4	$89K	Hold	12,000	–	–	﹤0.01%	964
2020 Q3	$72K	Buy	+12,000	New	+$60.3K	﹤0.01%	865
2020 Q2	–	Sell	-12,000	Closed	-$43K	–	636
2020 Q1	$43K	Hold	12,000	–	–	﹤0.01%	829
2019 Q4	$87K	Hold	12,000	–	–	﹤0.01%	883
2019 Q3	$77K	Hold	12,000	–	–	﹤0.01%	873
2019 Q2	$108K	Buy	+12,000	New	+$94.2K	﹤0.01%	901
2019 Q1	–	Sell	-12,000	Closed	-$77K	–	928
2018 Q4	$77K	Hold	12,000	–	–	﹤0.01%	851
2018 Q3	$58K	Buy	12,000 +6,000	+100%	+$14.8K	﹤0.01%	946
2018 Q2	$7K	Buy	+6,000	New	+$6.94K	﹤0.01%	1642

Other funds holding CRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

CIBC Private Wealth Group's CRMD Position: Q4 2025 in Review

CIBC Private Wealth Group held its CorMedix (CRMD) position steady in Q4 2025 at 42,000 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

CIBC Private Wealth Group first reported a position in CRMD in Q2 2018 and has held it in 29 quarters since. The position peaked at $517K in Q2 2025. 198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.

CIBC Private Wealth Group held 42,000 shares of CorMedix worth $488K as of Q4 2025.
CIBC Private Wealth Group left its CorMedix share count unchanged in Q4 2025.
CorMedix made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #888 holding.
CIBC Private Wealth Group first reported a position in CorMedix in Q2 2018 and has held it in 29 quarters since.
CIBC Private Wealth Group's CorMedix position peaked at $517K in Q2 2025.
198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.